The drugmaker has begun the process of searching for Philip Hamptonwill’s successor.
On Monday, drugmaker GlaxoSmithKline plc stated, Philip Hamptonwill, its chairman will be stepping down from his role.
Hamptonwill has been GlaxoSmithKline’s chairman for more than three and a half years.
GSK stated, it has begun the process of searching for Hamptonwill’s successor.
Britain’s competition authority likely to rule on Sainsbury’s-Asda $66 billion merger in early March ›
Categories: Creativity, Entrepreneurship, HR & Organization, Strategy
manageria.biz 
Leave a comment